Pub Date : 2021-06-30DOI: 10.31117/neuroscirn.v4i2.89
K. Ling, N. M. Abdul-Aziz, N. Nordin
Neuroscience Research Notes (ISSN: 2576-828X) was established in 2018 by a group of neuroscientists out of frustration and struggle to pay off any article processing charges for open access publication. Ever since its establishment, the journal has been steered to cater to high quality, short research and technical reports in all aspects of the nervous system. The journal emphasises hypothesis formation, research methodology, data interpretation and conclusion derived from both positive and negative findings, orphaned studies or neglected observations of related research fields. To date, the journal has received 66 submissions, with a 27% rejection rate. The average number of days for an editor to reach the first decision to accept any manuscript for further peer-reviewing is 5-day. However, it takes about 80-98 days (3 months) from submitting an article to final publication or rejection. The timeline of publishing with Neuroscience Research Notes is considered competitive and reasonable in fulfilling authors’ interest in having their research published as soon as possible while safeguarding the sanctity of the scientific peer-reviewing process.
《神经科学研究笔记》(Neuroscience Research Notes, ISSN: 2576-828X)是由一群神经科学家出于支付开放获取出版物的文章处理费的沮丧和挣扎于2018年创建的。自创刊以来，该杂志一直致力于在神经系统的各个方面提供高质量、简短的研究和技术报告。该杂志强调假设的形成、研究方法、数据解释和从积极和消极的发现中得出的结论、孤立的研究或忽视相关研究领域的观察。迄今为止，该杂志已收到66份投稿，拒绝率为27%。编辑首次决定接受稿件进行进一步同行评议的平均时间为5天。然而，从投稿到最终发表或退稿大约需要80-98天(3个月)。在《神经科学研究笔记》上发表论文的时间被认为是有竞争力和合理的，既能满足作者尽快发表研究成果的兴趣，又能维护科学同行评审过程的神圣性。
{"title":"Unity through diversity in neuroscience: A journey into Scopus indexation","authors":"K. Ling, N. M. Abdul-Aziz, N. Nordin","doi":"10.31117/neuroscirn.v4i2.89","DOIUrl":"https://doi.org/10.31117/neuroscirn.v4i2.89","url":null,"abstract":"Neuroscience Research Notes (ISSN: 2576-828X) was established in 2018 by a group of neuroscientists out of frustration and struggle to pay off any article processing charges for open access publication. Ever since its establishment, the journal has been steered to cater to high quality, short research and technical reports in all aspects of the nervous system. The journal emphasises hypothesis formation, research methodology, data interpretation and conclusion derived from both positive and negative findings, orphaned studies or neglected observations of related research fields. To date, the journal has received 66 submissions, with a 27% rejection rate. The average number of days for an editor to reach the first decision to accept any manuscript for further peer-reviewing is 5-day. However, it takes about 80-98 days (3 months) from submitting an article to final publication or rejection. The timeline of publishing with Neuroscience Research Notes is considered competitive and reasonable in fulfilling authors’ interest in having their research published as soon as possible while safeguarding the sanctity of the scientific peer-reviewing process.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47880017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-06-30DOI: 10.31117/neuroscirn.v4i2.81
Thaarvena Retinasamy, M. Shaikh
The US FDA approved Aducanumab in June 2021 as the first Alzheimer's disease (AD) drug under its accelerated approval pathway. It has given some hope to patients suffering from AD around the world. Aducanumab is an antibody that targets one of the well-known key culprits of this disease, known as amyloid-beta (Aβ). The journey of Aducanumab was bumpy, and there are controversies around the rapid approval of this drug AD treatment. This article highlights the potential of Aducanumab in AD, its mode of action and controversies around it.
{"title":"Aducanumab for Alzheimer's disease: An update","authors":"Thaarvena Retinasamy, M. Shaikh","doi":"10.31117/neuroscirn.v4i2.81","DOIUrl":"https://doi.org/10.31117/neuroscirn.v4i2.81","url":null,"abstract":"The US FDA approved Aducanumab in June 2021 as the first Alzheimer's disease (AD) drug under its accelerated approval pathway. It has given some hope to patients suffering from AD around the world. Aducanumab is an antibody that targets one of the well-known key culprits of this disease, known as amyloid-beta (Aβ). The journey of Aducanumab was bumpy, and there are controversies around the rapid approval of this drug AD treatment. This article highlights the potential of Aducanumab in AD, its mode of action and controversies around it.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46850816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-06-02DOI: 10.31117/NEUROSCIRN.V3I5.68
Tamara Hummadi, Indranath Chatterjee
Brain-computer interface's (BCI) potential applications increased tremendously over the past decade. The rising of this new technology is providing promising solutions in the field of aerospace and space exploration. As astronauts face diverse challenges in long-duration spaceflight, BCI can help astronauts deal with complicated tasks with a minimal mental workload. It may provide intelligent communication systems, maximize safety and security, facilitate space discovery missions, and enhance astronauts' overall health and wellbeing. In new ventures such as SpaceX, Starlink, and Neuralink, pioneers adopt futuristic strategies that use BCI as their main anchor. Such efforts are valuable in neuroscience as they will reveal information that will allow neuroscientists to deeper understand the brain's mechanisms.
{"title":"An era of brain-computer interface: BCI migration into space","authors":"Tamara Hummadi, Indranath Chatterjee","doi":"10.31117/NEUROSCIRN.V3I5.68","DOIUrl":"https://doi.org/10.31117/NEUROSCIRN.V3I5.68","url":null,"abstract":"Brain-computer interface's (BCI) potential applications increased tremendously over the past decade. The rising of this new technology is providing promising solutions in the field of aerospace and space exploration. As astronauts face diverse challenges in long-duration spaceflight, BCI can help astronauts deal with complicated tasks with a minimal mental workload. It may provide intelligent communication systems, maximize safety and security, facilitate space discovery missions, and enhance astronauts' overall health and wellbeing. In new ventures such as SpaceX, Starlink, and Neuralink, pioneers adopt futuristic strategies that use BCI as their main anchor. Such efforts are valuable in neuroscience as they will reveal information that will allow neuroscientists to deeper understand the brain's mechanisms.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47188612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-15DOI: 10.31117/NEUROSCIRN.V4I1.62
Shahidee Zainal Abidin, Han-Chung Lee, S. Abdullah, N. Nordin, P. Cheah, K. Ling
MicroRNA-3099 (miR-3099) plays a crucial role in regulating neuronal differentiation and development of the central nervous system (CNS). The miR-3099 is a pro-neuronal miRNA that promotes neural stem/progenitor cell (NSPC) differentiation into neuronal lineage by suppressing astrogliogenesis. Down syndrome (DS) brain exhibited increased astrogliogenesis and reduced neuronal cell density. The involvement of miR-3099 in the neurodevelopment of DS has not been investigated and potentially responsible for the neurogenic-to-gliogenic shift phenomenon observed in DS brain. To investigate the role of miR-3099 during DS brain development, neural/progenitor cell proliferation and differentiation, we profiled miR-3099 expression level in the Ts1Cje, a mouse model for DS. We analysed the Ts1Cje whole brain at embryonic day (E) 10.5, E14.5 and P1.5, proliferating neurospheres and differentiating neurospheres at 3, 9 and 15 days in vitro (DIV). Expression of miR-3099 in both the developing mouse brain and the differentiating neurosphere was not significantly different between Ts1Cje and wild type controls. In contrast, the expression level of miR-3099 was significantly higher (p<0.05) in proliferating NSPC derived from the Ts1Cje compared to wild-type. Further molecular profiling of NPSC and glial cell markers indicated that the expression of Sox2 (p<0.01) and Gfap (p<0.05) were significantly downregulated in Ts1Cje neurospheres as compared to that of wild type, respectively. While there were no significant differences in Tuj1 and Nestin expression levels between the Ts1Cje and wild type neurospheres, their expression levels were ~3-fold upregulated and ~2.6 downregulated Ts1Cje group, respectively. The findings suggest that dysregulation of miR-3099 affects NSPC lineage commitment as indicated by altered postmitotic neuronal cell markers. Further molecular characterisation and gene expression profiling of other neuronal and glial markers will help refine the analysis of gene-gene interactions underlying the neuropathologies of DS.
{"title":"The expression profile of miR-3099 during neural development of Ts1Cje mouse model of Down syndrome","authors":"Shahidee Zainal Abidin, Han-Chung Lee, S. Abdullah, N. Nordin, P. Cheah, K. Ling","doi":"10.31117/NEUROSCIRN.V4I1.62","DOIUrl":"https://doi.org/10.31117/NEUROSCIRN.V4I1.62","url":null,"abstract":"MicroRNA-3099 (miR-3099) plays a crucial role in regulating neuronal differentiation and development of the central nervous system (CNS). The miR-3099 is a pro-neuronal miRNA that promotes neural stem/progenitor cell (NSPC) differentiation into neuronal lineage by suppressing astrogliogenesis. Down syndrome (DS) brain exhibited increased astrogliogenesis and reduced neuronal cell density. The involvement of miR-3099 in the neurodevelopment of DS has not been investigated and potentially responsible for the neurogenic-to-gliogenic shift phenomenon observed in DS brain. To investigate the role of miR-3099 during DS brain development, neural/progenitor cell proliferation and differentiation, we profiled miR-3099 expression level in the Ts1Cje, a mouse model for DS. We analysed the Ts1Cje whole brain at embryonic day (E) 10.5, E14.5 and P1.5, proliferating neurospheres and differentiating neurospheres at 3, 9 and 15 days in vitro (DIV). Expression of miR-3099 in both the developing mouse brain and the differentiating neurosphere was not significantly different between Ts1Cje and wild type controls. In contrast, the expression level of miR-3099 was significantly higher (p<0.05) in proliferating NSPC derived from the Ts1Cje compared to wild-type. Further molecular profiling of NPSC and glial cell markers indicated that the expression of Sox2 (p<0.01) and Gfap (p<0.05) were significantly downregulated in Ts1Cje neurospheres as compared to that of wild type, respectively. While there were no significant differences in Tuj1 and Nestin expression levels between the Ts1Cje and wild type neurospheres, their expression levels were ~3-fold upregulated and ~2.6 downregulated Ts1Cje group, respectively. The findings suggest that dysregulation of miR-3099 affects NSPC lineage commitment as indicated by altered postmitotic neuronal cell markers. Further molecular characterisation and gene expression profiling of other neuronal and glial markers will help refine the analysis of gene-gene interactions underlying the neuropathologies of DS.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41750593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-02-26DOI: 10.31117/NEUROSCIRN.V4I1.60
U. Garkuwa, Buhari Ibrahim, Aisha Balanmalam, S. Muhammad, Mustapha Muazu, H. Garkuwa, A. Yakubu
Curcuma longa (C. longa), also known as curcumin, is a lipophilic polyphenol substance proven to have cholesterol-lowering, anti-diabetic, anti-inflammatory, anti-oxidant, and anti-cancer properties in both in vitro and in vivo models. Most previous studies investigated the effect of C. longa on diabetic mice and therefore, there is a need to investigate the effect of C. longa on normoglycemic mice. Depression is a common consequence of anxiety that affects 21% of the world’s population. Since the prevalence of diabetes and depression is on the rise globally, it is important to search for safer and cost-effective management for these disorders. In doing so, it is therefore essential to investigate its effect in normoglycemic mice. The current study determines the effect of C. longa on blood glucose level and anxiety-like behavior in normoglycemic Swiss albino mice. A total of 20 mice were divided into four groups of five (n=5 per group). Group I (control) received distilled water 10 ml/kg, groups II, III, and IV received C. longa at 5%, 10%, and 20%, respectively, for 14 days. We found that 20% C. longa group showed a significant (p<0.05) increase in fasting blood glucose level (195.84±14.46 mg/dl) after 14 days of administration compared with the control group (134.60±4.52 mg/dl). We also found that 20% C. longa increased the anxiety-like behavior in normoglycemic Swiss albino mice compared with the control group. However, there was no significant (p>0.05) difference in both fasting blood glucose level and anxiety-like behavior between the mice treated with 5% and 10% C. longa and the control group. This study indicates that C. longa at high concentration is unsafe for consumption by normoglycemic Swiss albino mice.
{"title":"Curcuma longa supplement increases anxiety-like behavior and blood glucose level in Swiss albino mice","authors":"U. Garkuwa, Buhari Ibrahim, Aisha Balanmalam, S. Muhammad, Mustapha Muazu, H. Garkuwa, A. Yakubu","doi":"10.31117/NEUROSCIRN.V4I1.60","DOIUrl":"https://doi.org/10.31117/NEUROSCIRN.V4I1.60","url":null,"abstract":"Curcuma longa (C. longa), also known as curcumin, is a lipophilic polyphenol substance proven to have cholesterol-lowering, anti-diabetic, anti-inflammatory, anti-oxidant, and anti-cancer properties in both in vitro and in vivo models. Most previous studies investigated the effect of C. longa on diabetic mice and therefore, there is a need to investigate the effect of C. longa on normoglycemic mice. Depression is a common consequence of anxiety that affects 21% of the world’s population. Since the prevalence of diabetes and depression is on the rise globally, it is important to search for safer and cost-effective management for these disorders. In doing so, it is therefore essential to investigate its effect in normoglycemic mice. The current study determines the effect of C. longa on blood glucose level and anxiety-like behavior in normoglycemic Swiss albino mice. A total of 20 mice were divided into four groups of five (n=5 per group). Group I (control) received distilled water 10 ml/kg, groups II, III, and IV received C. longa at 5%, 10%, and 20%, respectively, for 14 days. We found that 20% C. longa group showed a significant (p<0.05) increase in fasting blood glucose level (195.84±14.46 mg/dl) after 14 days of administration compared with the control group (134.60±4.52 mg/dl). We also found that 20% C. longa increased the anxiety-like behavior in normoglycemic Swiss albino mice compared with the control group. However, there was no significant (p>0.05) difference in both fasting blood glucose level and anxiety-like behavior between the mice treated with 5% and 10% C. longa and the control group. This study indicates that C. longa at high concentration is unsafe for consumption by normoglycemic Swiss albino mice.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42994663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-31DOI: 10.31117/neuroscirn.v3i4.61
Benneth Chiemelie Iloka, Grace Ifeoma Anukwe
Following technological advancements, the marketing world has witnessed a tremendous introduction of technologies that aid decision making. The essence is that through the adoption of such technologies, the marketers will make more informed decisions. Neuromarketing is a new marketing field that has witnessed increased penetration of technologies. As a field, it is centred on understanding the human brain's functionality when exposed to marketing activities. This article reviews eye-tracking as a neuromarketing tool. The review represents ideas from different scholars concerning the topic, concisely condensed to form the views held in this article. Findings from the review show that eye-tracking is one of the most commonly adopted neuromarketing tools because it is easier to access and implement with other tools. On the same note, some limitations come with this tool. The review concluded by stating that the best results with eye-tracking are obtained when combined with other tools to overcome these limitations and produce more informed data for better decisions and customer service.
{"title":"Review of eye-tracking: A neuromarketing technique","authors":"Benneth Chiemelie Iloka, Grace Ifeoma Anukwe","doi":"10.31117/neuroscirn.v3i4.61","DOIUrl":"https://doi.org/10.31117/neuroscirn.v3i4.61","url":null,"abstract":"Following technological advancements, the marketing world has witnessed a tremendous introduction of technologies that aid decision making. The essence is that through the adoption of such technologies, the marketers will make more informed decisions. Neuromarketing is a new marketing field that has witnessed increased penetration of technologies. As a field, it is centred on understanding the human brain's functionality when exposed to marketing activities. This article reviews eye-tracking as a neuromarketing tool. The review represents ideas from different scholars concerning the topic, concisely condensed to form the views held in this article. Findings from the review show that eye-tracking is one of the most commonly adopted neuromarketing tools because it is easier to access and implement with other tools. On the same note, some limitations come with this tool. The review concluded by stating that the best results with eye-tracking are obtained when combined with other tools to overcome these limitations and produce more informed data for better decisions and customer service.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48789724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-03DOI: 10.31117/neuroscirn.v3i4.58
Aida Azlina Bt. Mansor, S. Isa
Neuromarketing has become a central marketing issue in the new global economy. The term neuromarketing is a combination of neuroscience and marketing. This new concept provides new insights and powerful techniques in marketing research, especially on consumer analysis. The central concept of neuromarketing is strongly related to brain activities, understanding the consumers' subconscious mind, explaining consumers' preferences, motivations, and expectations, and predicting consumers' behavior. Neuromarketing is not to replace traditional marketing methods, but rather to provide unique and complementary insights. This paper focuses on the growing field of neuromarketing and aims to explain the fundamental concepts of neuromarketing to ensure that its unexplored practical usefulness can positively contribute to the field of marketing. Therefore, this review will help researchers to develop effective approaches further, to provide better and more efficient services to consumers through the use of scientific methods to understand how consumers respond to marketing campaigns.
{"title":"Fundamentals of neuromarketing: What is it all about?","authors":"Aida Azlina Bt. Mansor, S. Isa","doi":"10.31117/neuroscirn.v3i4.58","DOIUrl":"https://doi.org/10.31117/neuroscirn.v3i4.58","url":null,"abstract":"Neuromarketing has become a central marketing issue in the new global economy. The term neuromarketing is a combination of neuroscience and marketing. This new concept provides new insights and powerful techniques in marketing research, especially on consumer analysis. The central concept of neuromarketing is strongly related to brain activities, understanding the consumers' subconscious mind, explaining consumers' preferences, motivations, and expectations, and predicting consumers' behavior. Neuromarketing is not to replace traditional marketing methods, but rather to provide unique and complementary insights. This paper focuses on the growing field of neuromarketing and aims to explain the fundamental concepts of neuromarketing to ensure that its unexplored practical usefulness can positively contribute to the field of marketing. Therefore, this review will help researchers to develop effective approaches further, to provide better and more efficient services to consumers through the use of scientific methods to understand how consumers respond to marketing campaigns.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44660055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-05DOI: 10.31117/neuroscirn.v3i4.52
Alina Arulsamy, M. Shaikh
Traumatic brain injury (TBI) is a major cause of death and disability worldwide. In 2009, the National Trauma Database Malaysia reported that nearly 80% of traumas in the population were caused by road traffic accidents, with 64% of these cases related to TBI. Despite these concerning reports, TBI reporting systems and research are still limited in Malaysia. Thus, this systematic review aimed to identify and evaluate the available literature on TBI in Malaysia in order to uncover the status of TBI research in Malaysia. A comprehensive literature search was performed on four databases (PubMed, Embase, Medline and Scopus) regarding TBI in Malaysia. Critical evaluation of 60 relevant articles after application of inclusion and exclusion criteria have indicated that TBI research in Malaysia may have significant limitations in representing the actual TBI population and was lacking in basic TBI research. Thus, there is a dire need for government and private institutions to provide support for the advancement of TBI reporting and the progression of basic, clinical and translation TBI research in Malaysia. This will create a deeper understanding of TBI, contributing to global TBI knowledge, and advancing the development of efficient interventions for Malaysians with its population heterogeneity taken into consideration.
{"title":"Current status of traumatic brain injury research in Malaysia: A systematic review","authors":"Alina Arulsamy, M. Shaikh","doi":"10.31117/neuroscirn.v3i4.52","DOIUrl":"https://doi.org/10.31117/neuroscirn.v3i4.52","url":null,"abstract":"Traumatic brain injury (TBI) is a major cause of death and disability worldwide. In 2009, the National Trauma Database Malaysia reported that nearly 80% of traumas in the population were caused by road traffic accidents, with 64% of these cases related to TBI. Despite these concerning reports, TBI reporting systems and research are still limited in Malaysia. Thus, this systematic review aimed to identify and evaluate the available literature on TBI in Malaysia in order to uncover the status of TBI research in Malaysia. A comprehensive literature search was performed on four databases (PubMed, Embase, Medline and Scopus) regarding TBI in Malaysia. Critical evaluation of 60 relevant articles after application of inclusion and exclusion criteria have indicated that TBI research in Malaysia may have significant limitations in representing the actual TBI population and was lacking in basic TBI research. Thus, there is a dire need for government and private institutions to provide support for the advancement of TBI reporting and the progression of basic, clinical and translation TBI research in Malaysia. This will create a deeper understanding of TBI, contributing to global TBI knowledge, and advancing the development of efficient interventions for Malaysians with its population heterogeneity taken into consideration.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44220629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-20DOI: 10.31117/NEUROSCIRN.V3I3.54
Benneth Chiemelie Iloka, Kenechi John Onyeke
Neuroscience, the study of the brain and how humans process their daily activities, has always been part of other fields (such as neuropsychology in the psychological context). However, 2002 is known as the year neuromarketing was first coined by Professor Ale Smidts, describing it as the study of the brain and how it processes activities about consumer context (purchase behavior – how and why they buy). Further reviews showed that before coining the term, companies were already adopting neuromarketing through systems such as functional Magnetic Resonance Imaging (fMRI). To further demonstrate its essence, this review discussed its historical dimension, and findings show that it is a revolutionary area of marketing. Although limited empirical studies have been conducted within the context of neuromarketing, the review shows that it can address the challenges of reliability, validity, and generalizability that come with the conventional approaches in marketing research. However, it is suggested that the field of neuromarketing needs empirically-based works, urgently.
{"title":"Neuromarketing: a historical review","authors":"Benneth Chiemelie Iloka, Kenechi John Onyeke","doi":"10.31117/NEUROSCIRN.V3I3.54","DOIUrl":"https://doi.org/10.31117/NEUROSCIRN.V3I3.54","url":null,"abstract":"Neuroscience, the study of the brain and how humans process their daily activities, has always been part of other fields (such as neuropsychology in the psychological context). However, 2002 is known as the year neuromarketing was first coined by Professor Ale Smidts, describing it as the study of the brain and how it processes activities about consumer context (purchase behavior – how and why they buy). Further reviews showed that before coining the term, companies were already adopting neuromarketing through systems such as functional Magnetic Resonance Imaging (fMRI). To further demonstrate its essence, this review discussed its historical dimension, and findings show that it is a revolutionary area of marketing. Although limited empirical studies have been conducted within the context of neuromarketing, the review shows that it can address the challenges of reliability, validity, and generalizability that come with the conventional approaches in marketing research. However, it is suggested that the field of neuromarketing needs empirically-based works, urgently.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44145794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-27DOI: 10.31117/neuroscirn.v3i3.50
Asraa Faris, P. Cheah, K. Ling
Brain-derived neurotrophic factor (BDNF) is the most abundant neurotrophin in the central nervous system and was shown to be involved in neuronal growth, differentiation and synaptic plasticity. A single nucleotide polymorphism at the pro-region of the BDNF gene (rs6265) has been reported to alter the amino acid from valine to methionine at codon 66 and was associated with neuropsychiatric disorders in several studies. To date, the results on the association of BDNF rs6265 to the aetiology of the neuropsychiatric illnesses have been inconsistent with some studies reporting a positive association and others reporting no association. Concerning the past inconsistent reports, this mini-review aims at determining the association of BDNF rs6265 and neuropsychiatric disorders among the different studies. Firstly, we discuss the findings on studies reporting the association of BDNF rs6265 with depression whereby a positive association between the BDNF variant and depression was obtained in several studies on the Caucasian, German, Chinese, and Malaysian population but not in studies on the Korean and other populations. Likewise, some studies found the occurrence of the SNP to be associated with a reduction in the BDNF level in depressed cases, but others found no effect at all. We then reported findings on the association of BDNF rs6265 with anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, bipolar disorder, and schizophrenia. Val allele has been found associated with these disorders, whereas some studies reported the involvement of the Met allele, and some reported no association at all. Similarly, the association of the BDNF variant with the BDNF level remains controversial. It is, therefore, essential to conduct more studies with larger sample sizes and look at the haplotype level to determine the association.
{"title":"Single nucleotide polymorphism of BDNF Val66Met (rs6265) and its association to neuropsychiatric disorders","authors":"Asraa Faris, P. Cheah, K. Ling","doi":"10.31117/neuroscirn.v3i3.50","DOIUrl":"https://doi.org/10.31117/neuroscirn.v3i3.50","url":null,"abstract":"Brain-derived neurotrophic factor (BDNF) is the most abundant neurotrophin in the central nervous system and was shown to be involved in neuronal growth, differentiation and synaptic plasticity. A single nucleotide polymorphism at the pro-region of the BDNF gene (rs6265) has been reported to alter the amino acid from valine to methionine at codon 66 and was associated with neuropsychiatric disorders in several studies. To date, the results on the association of BDNF rs6265 to the aetiology of the neuropsychiatric illnesses have been inconsistent with some studies reporting a positive association and others reporting no association. Concerning the past inconsistent reports, this mini-review aims at determining the association of BDNF rs6265 and neuropsychiatric disorders among the different studies. Firstly, we discuss the findings on studies reporting the association of BDNF rs6265 with depression whereby a positive association between the BDNF variant and depression was obtained in several studies on the Caucasian, German, Chinese, and Malaysian population but not in studies on the Korean and other populations. Likewise, some studies found the occurrence of the SNP to be associated with a reduction in the BDNF level in depressed cases, but others found no effect at all. We then reported findings on the association of BDNF rs6265 with anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, bipolar disorder, and schizophrenia. Val allele has been found associated with these disorders, whereas some studies reported the involvement of the Met allele, and some reported no association at all. Similarly, the association of the BDNF variant with the BDNF level remains controversial. It is, therefore, essential to conduct more studies with larger sample sizes and look at the haplotype level to determine the association.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49046354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：